This and other studies suggested that gene therapy based on overexpression of NPY alone or in combination with Y2 receptors might provide an alternative treatment strategy for drug-resistant temporal lobe epilepsy (TLE)6,11,21. This evidence concerns the gene NPY and temporal lobe epilepsy.